MetLife Investment Management’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142K | Buy |
+115,813
| New | +$142K | ﹤0.01% | 2364 |
|
|
2023
Q1 | – | Sell |
-5,906
| Closed | -$12.8K | – | 2802 |
|
|
2022
Q4 | $12.8K | Sell |
5,906
-28,730
| -83% | -$62.3K | ﹤0.01% | 2826 |
|
|
2022
Q3 | $415K | Buy |
34,636
+3,846
| +12% | +$46.1K | ﹤0.01% | 1769 |
|
|
2022
Q2 | $258K | Sell |
30,790
-4,450
| -13% | -$37.2K | ﹤0.01% | 2133 |
|
|
2022
Q1 | $306K | Buy |
35,240
+12,565
| +55% | +$109K | ﹤0.01% | 2081 |
|
|
2021
Q4 | $256K | Buy |
22,675
+5,987
| +36% | +$67.7K | ﹤0.01% | 1906 |
|
|
2021
Q3 | $210K | Sell |
16,688
-7,791
| -32% | -$97.9K | ﹤0.01% | 2072 |
|
|
2021
Q2 | $199K | Buy |
24,479
+13,322
| +119% | +$108K | ﹤0.01% | 2180 |
|
|
2021
Q1 | $103K | Sell |
11,157
-11,841
| -51% | -$110K | ﹤0.01% | 2248 |
|
|
2020
Q4 | $222K | Hold |
22,998
| – | – | ﹤0.01% | 1922 |
|
|
2020
Q3 | $285K | Hold |
22,998
| – | – | ﹤0.01% | 1656 |
|
|
2020
Q2 | $299K | Buy |
22,998
+3,357
| +17% | +$43.6K | ﹤0.01% | 1656 |
|
|
2020
Q1 | $199K | Hold |
19,641
| – | – | ﹤0.01% | 1698 |
|
|
2019
Q4 | $307K | Hold |
19,641
| – | – | ﹤0.01% | 1733 |
|
|
2019
Q3 | $330K | Buy |
19,641
+9,655
| +97% | +$162K | ﹤0.01% | 1653 |
|
|
2019
Q2 | $221K | Buy |
+9,986
| New | +$221K | ﹤0.01% | 1972 |
|